News
EVGN
0.4647
-9.24%
-0.0473
Weekly Report: what happened at EVGN last week (0706-0710)?
Weekly Report · 20h ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 4d ago
Evogene, BCDD announces strategic joint initiative
TipRanks · 5d ago
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
PR Newswire · 5d ago
Weekly Report: what happened at EVGN last week (0629-0703)?
Weekly Report · 07/06 10:10
Weekly Report: what happened at EVGN last week (0622-0626)?
Weekly Report · 06/29 10:05
Evogene achieves integration of agentic systems with ChemPass AI platform
TipRanks · 06/24 12:10
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 06/24 12:05
Weekly Report: what happened at EVGN last week (0615-0619)?
Weekly Report · 06/22 10:13
Evogene Showcases AI-Driven ChemPass Platform and Expanded Google Cloud Collaboration in New Investor Deck
TipRanks · 06/16 12:28
Weekly Report: what happened at EVGN last week (0608-0612)?
Weekly Report · 06/15 10:14
Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
TipRanks · 06/11 20:28
Full Transcript: Evogene Q1 2026 Earnings Call
Benzinga · 06/11 10:51
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
PR Newswire · 06/09 11:00
Weekly Report: what happened at EVGN last week (0601-0605)?
Weekly Report · 06/08 10:10
Evogene Completes First-In-Human Phase 1 Clinical Study Of BMC128, Rationally-Designed Live Bacterial Product Developed By Its Subsidiary, Biomica, In Combination With Nivolumab In Patients With Advanced Solid Tumors
Benzinga · 06/02 11:10
Evogene says Phase 1 clinical study of BMC128 met primary endpoint
TipRanks · 06/02 11:06
Evogene Reports Early Results for Cancer Therapy Study, Experimental Treatment Meets Safety Goal in First Human Trial
Benzinga · 06/02 11:06
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
PR Newswire · 06/02 11:00
Weekly Report: what happened at EVGN last week (0525-0529)?
Weekly Report · 06/01 10:14
More
Webull provides a variety of real-time EVGN stock news. You can receive the latest news about Evogene through multiple platforms. This information may help you make smarter investment decisions.
About EVGN
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.